Drug Shortage Report for ROFACT

Last updated on 2019-10-09 History
Report ID 93236
Drug Identification Number 00393444
Brand name ROFACT
Common or Proper name ROFACT
Company Name BAUSCH HEALTH, CANADA INC.
Active Ingredient(s) RIFAMPIN
Strength(s) 150MG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size n/a
ATC code J04AB
ATC description DRUGS FOR TREATMENT OF TUBERCULOSIS
Reason for shortage Shortage of an active ingredient.
Anticipated start date 2019-12-16
Actual start date
Estimated end date Unknown
Actual end date
Shortage status Anticipated shortage
Updated date 2019-10-09
Company comments currently on manual allocation
Health Canada comments
Contact Address 2150 BOUL. ST-ELZEAR OUEST
LAVAL, QUEBEC
CANADA H7L 4A8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2019-10-09 French Compare
v9 2019-10-09 English Compare
v8 2019-10-09 English Compare
v7 2019-09-09 French Compare
v6 2019-09-09 English Compare
v5 2019-09-09 French Compare
v4 2019-09-09 English Compare
v3 2019-09-09 English Compare
v2 2019-09-06 French Compare
v1 2019-09-06 English Compare